<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A2CE443A-4218-4D0E-AA0A-BB0C73680D8D"><gtr:id>A2CE443A-4218-4D0E-AA0A-BB0C73680D8D</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Gering</gtr:surname><gtr:orcidId>0000-0003-3763-0885</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601134"><gtr:id>CC0C222D-6B4D-4289-AAA8-EA753EFCC0E6</gtr:id><gtr:title>Generation of a c-myb reporter line for functional testing of haematopoietic stem cells isolated from zebrafish embryos</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601134</gtr:grantReference><gtr:abstractText>We are dissecting the molecular mechanisms that control formation and maintenance of blood/haematopoietic stem cells (HSCs) in zebrafish embryos. 

In vertebrates, HSCs form during embryogenesis. In adult humans, they reside in the bone marrow from where they replace short-lived mature blood cells throughout life. Thus, they are essential for our survival. They are the active component of bone marrow transplants that are used to re-establish blood formation (haematopoiesis) in patients that have lost their blood system due to blood disorders, accidents or medical treatments. 

To develop new therapies, we need to be able to generate HSCs in vitro and to maintain and expand their numbers. To date, we know little about the molecular mechanisms that control these processes. 

We study zebrafish embryos with the aim to reveal these mechanisms. While we can identify the earliest potential HSCs by gene expression, we currently lack an assay to test them. Therefore, we are generating a transgenic fish line in which these cells express a green fluorescent protein. Fluorescent cells will be transplanted from a transgenic to a wild-type embryo to see whether they participate in long-term haematopoiesis. This assay will be an invaluable tool for dissecting the molecular mechanisms that control HSC biology.</gtr:abstractText><gtr:technicalSummary>Haematopoietic stem cells (HSCs) can self-renew and give rise to mature blood cells of all lineages. Thus, HSCs are essential for the homeostasis of the blood system and the long-term survival of the individual. HSCs first form during vertebrate embryogenesis in the second or definitive wave of haematopoiesis. The first or primitive wave merely gives rise to primitive red blood cells that are required for immediate gas exchange and die off quickly. The definitive wave generates the HSCs and occurs in close association with the ventral wall of the dorsal aorta (DA). 

Little is known about the molecular and cellular steps that lead to the formation of HSCs and that distinguish HSCs from the primitive blood cells. This is due to the late appearance of HSCs during ontogeny and the fact that primitive and definitive haematopoiesis share a number of key regulators as well as a common origin with the endothelium. Thus, loss of primitive blood or loss of blood circulation causes lethality prior to HSC emergence in mammalian embryos. By contrast, zebrafish embryos survive even in the absence of primitive blood circulation as they are small and develop externally, and gas exchange through passive diffusion through the skin is sufficient. This makes zebrafish an ideal vertebrate model to study HSC formation in. In zebrafish embryos, putative HSCs are found at 24 hours post fertilisation. They are defined by (a) the expression of HSC genes, like those for the transcription factors Runx1, c-Myb and Ikaros, and (b) the location of the cells in association with the ventral wall of the DA (Gering and Patient, 2005). A functional test of these cells is yet to be done. Here, I propose to functionally test the putative HSCs. 

To tag the putative HSCs, an RFP reporter gene shall be expressed in HSCs under the control of the c-myb regulatory elements in transgenic zebrafish. Red fluorescent cells will be isolated by flow cytometry and injected into host embryos. The cells will then be followed in the host to examine whether they can generate blood cells of all lineages for several months and, therefore, constitute HSCs or their precursors. Furthermore, these experiments will provide a functional HSC promoter that can be used for misexpression of transgenes in HSCs, and will allow the isolation of HSCs for transcriptome analysis in the future.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>338112</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Sunday Times Journalist</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4F068419-BAAE-48E1-A925-1893EBF07EE6</gtr:id><gtr:impact>A senior journalist, Richard Girling, of the Sunday Times is preaparing an article for the Sunday Times Magazine on biomedical research. He is particularly interested in the way we use genetically modified animals in biomedical research and in the impact that may have on future treatments in the clinic.

The meeting took place on the 21st October 2009. The article was eventually published on the 10th January 2010 under the title &amp;quot;How would you feel of you were an animal caged for scientific testing?&amp;quot;. While the title sounds worrying, the text is a fairly balanced account of the pros and cons in animal research. I hope that the article will contribute to a better understanding of biomedical research by the general public.</gtr:impact><gtr:outcomeId>1E3D425E3B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2350</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Actions - Initial Training Network Consortium for Vascular Biology (VESSEL) - Associated Partner</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>C225D220-EA1E-46A5-9453-5C040601A924</gtr:id><gtr:outcomeId>58c2e8a1ef2163.60242866</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>63000</gtr:amountPounds><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Government of Saudi Arabia</gtr:fundingOrg><gtr:fundingRef>4170955</gtr:fundingRef><gtr:id>A3B4B64A-0E8E-4FBD-95B6-B8560CE340B5</gtr:id><gtr:outcomeId>58c2ebf5779c02.15998025</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>488373</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J000841/1</gtr:fundingRef><gtr:id>E576B857-3223-4086-8B89-778586B1FCE1</gtr:id><gtr:outcomeId>eq5Dxa9V87i</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90920</gtr:amountPounds><gtr:country>Saudi Arabia, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Government of Saudi Arabia</gtr:fundingOrg><gtr:fundingRef>4243806</gtr:fundingRef><gtr:id>EF787ACA-5C0F-4DC0-8D0A-A8F9497A0893</gtr:id><gtr:outcomeId>58c6bb145a8fe0.05368817</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Studentship as part of BBSRC DTP (Biotechnology and Biological Sciences doctoral training programme)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>RS86AD</gtr:fundingRef><gtr:id>E30B77AA-7A25-48A4-9688-C7A3DE9F8C0B</gtr:id><gtr:outcomeId>58c2ecd51cb263.03929326</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>68350</gtr:amountPounds><gtr:country>Kuwait, State of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Kuwait University</gtr:fundingOrg><gtr:fundingRef>4258587</gtr:fundingRef><gtr:id>F2A64452-1373-4903-B984-40189B3859DB</gtr:id><gtr:outcomeId>58c69a2a782ca1.76040085</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is a transgenic line that highlights the onset of arterial specification of the dorsal aorta angioblasts in the zebrafish embryos. In addition, it allows us to follow efnb2a expression in a number of other tissues. The promoter element was provided by Richard Poole, a former PhD student in Steve Wilson's lab at UCL.</gtr:description><gtr:id>A78EE7E8-55B5-4AF1-A19D-3B001C408E06</gtr:id><gtr:impact>It can be used in combination with line I-551 to isolate GFP/Tomato-coexpressing cells from the ventral wall of the dorsal aorta. These are putative HSCs.</gtr:impact><gtr:outcomeId>4BBEF93D57B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>efnb2a-Tomato transgenic zebrafish reporter line</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using an enhancer trap approach we have generated a transgenic zebrafish line that expresses a GFP reporter gene in putative HSCs as they develop in the ventral wall of the dorsal aorta at 24 hours post-fertilisation. In combined fluorescent immunohistochemistry/fluorescent in situ hybridisation experiments we can show on the confocal microscope that in this line expression of GFP is found in indiividual cells that co-express mRNA for the transcription factors c-Myb and Runx1, two proteins that play essential roles in HSCs and progenitors. Embryos injected with a morpholino against Rbpj an essential component of the Notch signalling pathway that has been shown to be required for HSC emergence lose expression of c-myb and runx1 as well as transgene expression. The reporter is also expressed in primitive red blood cells. Its expression is maintained later in sites of active haematopoiesis. Analysis of the expression of the gene our gene trap has jumped into has revealed that the transposon effectively wiped out the expression of the trapped gene in HSC progenitors and has led to upregulation of a paralogous gene. In collaboration with a lab in Sheffield that has generated a knock-out of the paralogue we are keen to find out out what the phenotype of the double knock-out is. We have recently exchanged our lines.</gtr:description><gtr:id>348E1F18-05CB-4A5E-9C40-C0A2C4B83219</gtr:id><gtr:impact>In combination with red reporter lines (gata1-dsRed, flk1-Tomato and efnb2a-tomato) this line will allow us to isolate forming HSCs out of the zebrafish embryos for further analysis. This will include transplantation, tissue culture and biochemical analysis including transcriptome analysis. The line has been passed on to a collaborator in Sheffield.</gtr:impact><gtr:outcomeId>CECC2BA8BA3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic zebrafish line marking emerging HSCs, qmc551</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>By testing conserved non-coding sequence elements in the vicinity of the zebrafish c-myb gene for their ability to direct reporter gene expression from a minimal promoter element in haematopoietic cells in stable transgenic zebrafish lines we have identified a downstream enhancer element that drives reporter gene expression in putative HSCs located in the caudal haematopoietic tissue (CHT). The CHT a transient site of haematopoiesis in zebrafish that is believed to fulfil a role that is similar to that of the foetal liver in mammalian embryos.</gtr:description><gtr:id>D5715CFC-BE4A-45E7-8825-8A9324C6A807</gtr:id><gtr:impact>It will allow us to (a) observe HSC behaviour in vivo (b) isolate the cells out of the embryo for functional and biochemical analysis (c) use the enhancer elements to misexpress genes specifically in the cells it drives expression in.</gtr:impact><gtr:outcomeId>24384F04AAD</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>c-myb HSC enhancer element</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Three transgenic zebrafish line have been generated that allows the readout of Notch signalling in the developing zebrafish embryo. They carry fluorescent protein reporter transgenes (Venus, Cerulean, mCherry), the expression of which are driven by a rabbit beta-globin minimal promoter and 12 CSL (Su(H), Rbpj) binding sites.</gtr:description><gtr:id>02123A50-D008-47E4-87AE-B40A18127145</gtr:id><gtr:impact>This line will allow the analysis of Notch signalling not only in the vasculature and in the blood, but in a large range of other tissues that Notch signalling plays a pivotal role in. The line will be distributed to other researchers as soon as we have enough F1 fish and do no longer rely on the F0 founder fish for the generation of reporter embryos. In the last two years the Venus line has been passed on to researchers in Bath, at UCL and Sheffield.</gtr:impact><gtr:outcomeId>0B065746FD5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>zebrafish Notch reporter lines</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a transgenic zebrafish reporter line that expresses a Tomato reporter gene under the control of the endothelial flk1 promoter.</gtr:description><gtr:id>CCF241DD-E47A-4CB1-9BC1-E37C7C9891D0</gtr:id><gtr:impact>In combination with the I-551 line it will allow the isolation of emerging HSCs from the develoing embryo. These cells can then be used for functional analysis (in vivo and in vitro) and for biochemical analysis (incl. transcriptome analysis). Having different ways of isolating the same cell population will allow critical evaluation of experimental outcomes.</gtr:impact><gtr:outcomeId>AAD34A1F83B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>flk1-Tomato transgenic zebrafish reporter line</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5BD88178-8459-4B44-98EB-C35546D4211A</gtr:id><gtr:title>Loss of function of parathyroid hormone receptor 1 induces Notch-dependent aortic defects during zebrafish vascular development.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ae0e7ebdbeb48e17295c01f1e1c2f20"><gtr:id>7ae0e7ebdbeb48e17295c01f1e1c2f20</gtr:id><gtr:otherNames>Gray C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_12465_25_23559631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D4EF414-46B4-4211-8C81-033969766B37</gtr:id><gtr:title>Notch in the niche.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e98a57f63b7a5d80f53077907358c65"><gtr:id>4e98a57f63b7a5d80f53077907358c65</gtr:id><gtr:otherNames>Gering M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>7CEBE1E3206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98F96A7A-9D28-48AE-84D2-B0A50496E80B</gtr:id><gtr:title>The miR-30 microRNA family targets smoothened to regulate hedgehog signalling in zebrafish early muscle development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07a12283f0dab3df9ebfe8dbc12c7130"><gtr:id>07a12283f0dab3df9ebfe8dbc12c7130</gtr:id><gtr:otherNames>Ketley A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12465_25_23755189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF90AC0B-D2C6-4D9F-8E74-8E0A1A717A69</gtr:id><gtr:title>Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74ef6c05446c342f04774928d90c91f6"><gtr:id>74ef6c05446c342f04774928d90c91f6</gtr:id><gtr:otherNames>Watson O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>pm_12465_25_23812297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C61B07-D632-4F3B-B5A5-6DBF85BFB691</gtr:id><gtr:title>Hey2 acts upstream of Notch in hematopoietic stem cell specification in zebrafish embryos.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7fe73c02fcb8a83cdb9a2324d33ccdc"><gtr:id>a7fe73c02fcb8a83cdb9a2324d33ccdc</gtr:id><gtr:otherNames>Rowlinson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>AntekgXZBJo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E6B6CA8-D326-4E5E-9124-7B99F26640D2</gtr:id><gtr:title>NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In&amp;nbsp;Vivo.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4567fd8ee15a273550144bd1ab1c52af"><gtr:id>4567fd8ee15a273550144bd1ab1c52af</gtr:id><gtr:otherNames>Di Stefano M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>58c2efba3aad16.62751670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A4235BD-DDE3-42B2-ADDE-E9D1366ABCF6</gtr:id><gtr:title>Hedgehog and Bmp polarize hematopoietic stem cell emergence in the zebrafish dorsal aorta.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac862bf4cfa06d595d0678a9c893717"><gtr:id>2ac862bf4cfa06d595d0678a9c893717</gtr:id><gtr:otherNames>Wilkinson RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>C5279D67F6A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C2F22B7-431C-4CF4-9729-0A732CC9CD39</gtr:id><gtr:title>Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5729828fb87a41a97f714502736bcd74"><gtr:id>5729828fb87a41a97f714502736bcd74</gtr:id><gtr:otherNames>Loreto A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56dc491e658b79.09070547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C8B37CB-FA2F-4663-9042-8F6EB3537811</gtr:id><gtr:title>A gene trap transposon eliminates haematopoietic expression of zebrafish Gfi1aa, but does not interfere with haematopoiesis.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/389fbc17670ddcf503e58462dcef63e6"><gtr:id>389fbc17670ddcf503e58462dcef63e6</gtr:id><gtr:otherNames>Thambyrajah R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>585d6d98448431.47434377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64A23B98-0C4C-42BC-BBD2-0B7A97C104E1</gtr:id><gtr:title>5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/554888849f9058347fc5093fe6a0ca4f"><gtr:id>554888849f9058347fc5093fe6a0ca4f</gtr:id><gtr:otherNames>Almeida RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>pm_12465_25_22419071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>068685DF-4A2D-444C-AF82-BA0BD3D58D2F</gtr:id><gtr:title>Notch signalling and haematopoietic stem cell formation during embryogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e98a57f63b7a5d80f53077907358c65"><gtr:id>4e98a57f63b7a5d80f53077907358c65</gtr:id><gtr:otherNames>Gering M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>1385A9F98E1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601134</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>